As Nossas Leituras\Our Readings
Os níveis séricos de Cyfra 21-1 são factores preditivos da sobrevida dos doentes com carcinoma pulmonar de não pequenas células submetidos a gefitinib como terapêutica de terceira linha.
Cyfra 21-1 level predicts survival in non-small-cell lung cancer patients receiving gefitinib as third-line therapy.
F. Barlési, C. Tchouhadjian, C. Doddoli, J.-P. Torre, P. Astoul, J.-P. Kleisbauer
Read
4794
Timeswas read the article
2220
Total PDF
2574
Total HTML
Article information
ISSN: 08732159Original language: Portuguese
The statistics are updated each day
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 5 | 8 | 13 |
| 2025 5 | 43 | 48 | 91 |
| 2025 4 | 53 | 40 | 93 |
| 2025 3 | 42 | 26 | 68 |
| 2025 2 | 33 | 36 | 69 |
| 2025 1 | 30 | 35 | 65 |
| 2024 12 | 20 | 33 | 53 |
| 2024 11 | 33 | 37 | 70 |
| 2024 10 | 40 | 28 | 68 |
| 2024 9 | 28 | 25 | 53 |
| 2024 8 | 38 | 42 | 80 |
| 2024 7 | 25 | 45 | 70 |
| 2024 6 | 26 | 24 | 50 |
| 2024 5 | 28 | 29 | 57 |
| 2024 4 | 25 | 25 | 50 |
| 2024 3 | 24 | 22 | 46 |
| 2024 2 | 22 | 40 | 62 |
| 2024 1 | 21 | 31 | 52 |
| 2023 12 | 18 | 23 | 41 |
| 2023 11 | 13 | 21 | 34 |
| 2023 10 | 15 | 32 | 47 |
| 2023 9 | 15 | 30 | 45 |
| 2023 8 | 15 | 21 | 36 |
| 2023 7 | 22 | 18 | 40 |
| 2023 6 | 15 | 10 | 25 |
| 2023 5 | 21 | 19 | 40 |
| 2023 4 | 14 | 13 | 27 |
| 2023 3 | 24 | 28 | 52 |
| 2023 2 | 10 | 19 | 29 |
| 2023 1 | 14 | 16 | 30 |
| 2022 12 | 22 | 23 | 45 |
| 2022 11 | 21 | 27 | 48 |
| 2022 10 | 25 | 35 | 60 |
| 2022 9 | 13 | 29 | 42 |
| 2022 8 | 26 | 22 | 48 |
| 2022 7 | 15 | 37 | 52 |
| 2022 6 | 18 | 33 | 51 |
| 2022 5 | 25 | 34 | 59 |
| 2022 4 | 21 | 34 | 55 |
| 2022 3 | 22 | 31 | 53 |
| 2022 2 | 20 | 22 | 42 |
| 2022 1 | 16 | 34 | 50 |
| 2021 12 | 15 | 27 | 42 |
| 2021 11 | 16 | 22 | 38 |
| 2021 10 | 14 | 35 | 49 |
| 2021 9 | 16 | 25 | 41 |
| 2021 8 | 16 | 24 | 40 |
| 2021 7 | 14 | 20 | 34 |
| 2021 6 | 16 | 24 | 40 |
| 2021 5 | 27 | 30 | 57 |
| 2021 4 | 27 | 50 | 77 |
| 2021 3 | 34 | 16 | 50 |
| 2021 2 | 26 | 15 | 41 |
| 2021 1 | 24 | 18 | 42 |
| 2020 12 | 27 | 17 | 44 |
| 2020 11 | 27 | 17 | 44 |
| 2020 10 | 30 | 14 | 44 |
| 2020 9 | 29 | 18 | 47 |
| 2020 8 | 23 | 24 | 47 |
| 2020 7 | 38 | 17 | 55 |
| 2020 6 | 27 | 20 | 47 |
| 2020 5 | 34 | 21 | 55 |
| 2020 4 | 28 | 13 | 41 |
| 2020 3 | 28 | 11 | 39 |
| 2020 2 | 35 | 17 | 52 |
| 2020 1 | 34 | 12 | 46 |
| 2019 12 | 20 | 26 | 46 |
| 2019 11 | 39 | 14 | 53 |
| 2019 10 | 21 | 19 | 40 |
| 2019 9 | 28 | 14 | 42 |
| 2019 8 | 26 | 17 | 43 |
| 2019 7 | 16 | 11 | 27 |
| 2019 6 | 26 | 9 | 35 |
| 2019 5 | 28 | 17 | 45 |
| 2019 4 | 27 | 31 | 58 |
| 2019 3 | 42 | 14 | 56 |
| 2019 2 | 27 | 22 | 49 |
| 2019 1 | 26 | 21 | 47 |
| 2018 12 | 12 | 7 | 19 |
| 2018 11 | 10 | 1 | 11 |
| 2018 10 | 30 | 5 | 35 |
| 2018 9 | 9 | 6 | 15 |
| 2018 8 | 23 | 13 | 36 |
| 2018 7 | 34 | 11 | 45 |
| 2018 6 | 38 | 14 | 52 |
| 2018 5 | 40 | 17 | 57 |
| 2018 4 | 49 | 18 | 67 |
| 2018 3 | 38 | 12 | 50 |
| 2018 2 | 28 | 10 | 38 |
| 2018 1 | 25 | 15 | 40 |
| 2017 12 | 30 | 6 | 36 |
| 2017 11 | 32 | 19 | 51 |
| 2017 10 | 30 | 13 | 43 |
| 2017 9 | 26 | 10 | 36 |
| 2017 8 | 23 | 14 | 37 |
| 2017 7 | 11 | 3 | 14 |
| 2017 6 | 23 | 13 | 36 |
| 2017 5 | 27 | 6 | 33 |
| 2017 4 | 7 | 2 | 9 |
| 2017 3 | 15 | 18 | 33 |
| 2017 2 | 9 | 1 | 10 |
| 2017 1 | 10 | 4 | 14 |
| 2016 12 | 13 | 4 | 17 |
| 2016 11 | 7 | 6 | 13 |
| 2016 10 | 15 | 15 | 30 |
| 2016 9 | 3 | 1 | 4 |
| 2016 8 | 4 | 3 | 7 |
| 2016 7 | 3 | 7 | 10 |
| 2016 6 | 1 | 8 | 9 |
| 2016 5 | 7 | 0 | 7 |
| 2016 4 | 1 | 1 | 2 |
| 2016 3 | 9 | 8 | 17 |
| 2016 2 | 7 | 12 | 19 |
| 2016 1 | 4 | 2 | 6 |
| 2015 12 | 8 | 3 | 11 |
| 2015 11 | 2 | 1 | 3 |
| 2015 10 | 4 | 4 | 8 |
Show all
